articleAmerican Journal of OphthalmologyApr 20, 2009Closed access

A Variable-dosing Regimen with Intravitreal Ranibizumab for Neovascular Age-related Macular Degeneration: Year 2 of the PrONTO Study

GAGeeta A. LalwaniPJPhilip J. RosenfeldAEAnne E. FungSRSander R. DubovySMS. Michels

University of Miami

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

883
total citations
FWCI
69.41
Percentile
100%
References
15
Citations per year

Authors

9

Topics & keywords

Topics
Keywords
  • Ranibizumab
  • Medicine
  • Macular degeneration
  • Ophthalmology
  • Dosing
  • Visual acuity
  • Regimen
  • Prospective cohort study
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.